Protocol for identifying Mycobacterium tuberculosis infection status through airway microbiome profiling
Geoffrey Olweny1, Moses Levi Ntayi1, Edward Kyalo1
1Department of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala 256, Uganda; Lung Institute, Makerere University College of Health Sciences, Kampala 256, Uganda.
STAR Protocols
|January 18, 2025
Summary
This protocol details how to analyze airway microbiome data to identify Mycobacterium tuberculosis infection. It outlines methods for data processing, diversity analysis, and biomarker discovery for improved tuberculosis diagnostics.
Area of Science:
- Microbiology
- Infectious Diseases
- Bioinformatics
Background:
- Tuberculosis remains a global health challenge, necessitating improved diagnostic methods.
- The airway microbiome offers potential as a non-invasive biomarker for respiratory infections.
- Accurate identification of Mycobacterium tuberculosis infection status is crucial for effective treatment and control.
Purpose of the Study:
- To provide a standardized protocol for analyzing airway microbiome data.
- To establish a microbiome signature for identifying Mycobacterium tuberculosis infection.
- To guide the identification of potential biomarkers for tuberculosis diagnosis.
Main Methods:
- Standardized procedures for processing raw microbiome sequencing data.
- Calculation of alpha and beta diversity metrics to assess microbial community structure.
- Application of Dirichlet multinomial mixture models for microbiome profiling.
- Analysis of taxonomic relative and differential abundances.
- Identification of specific microbial taxa or patterns associated with M. tuberculosis infection.
Main Results:
- The protocol enables the generation of an airway microbiome signature.
- The signature can differentiate between M. tuberculosis infection status.
- Identified potential microbial biomarkers correlated with infection status.
Conclusions:
- Airway microbiome analysis is a viable approach for M. tuberculosis detection.
- This protocol facilitates reproducible research in respiratory microbiome diagnostics.
- Further validation may lead to novel diagnostic tools for tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis III
301
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
301
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170


